December, 2020 (4)

• A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX).
  Mazhari R, Brewster J, Fong R, Bourke C, Liu ZSJ, Takashima E, Tsuboi T, Tham WH, Harbers M, Chitnis C, Healer J, Ome-Kaius M, Sattabongkot J, Kazura J, Robinson LJ, King C, Mueller I, Longley RJ
  PLoS One. 2020 Dec; 15(12):e0238010
• Striving for hepatitis C elimination - the role of a vaccine.
  Hellard M, Drummer H, Scott N
  Clin Infect Dis. 2020 Dec; 77(11):2991-2992
• Effect of a mobile phone intervention for female sex workers on unintended pregnancy in Kenya (WHISPER or SHOUT): a cluster-randomised controlled trial.
  Ampt FH, Lim MSC, Agius PA, L'Engle K, Manguro G, Gichuki C, Gichangi P, Chersich MF, Jaoko W, Temmerman M, Stoové M, Hellard M, Luchters S
  Lancet Glob Health. 2020 Dec; 8(12):e1534-e1545
• Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
  Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, Scott N, Chhatwal J, Ball A
  Value Health. 2020 Dec; 23(12):1552-1560

November, 2020 (4)

• Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and Plasmodium falciparum infection risk in a cross-sectional survey in Mondulkiri province, Cambodia.
  Sandfort M, Vantaux A, Kim S, Obadia T, Pepey A, Gardais S, Khim N, Lek D, White M, Robinson LJ, Witkowski B, Mueller I
  Malar J. 2020 Nov; 19(1):413
• Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.
  Papaluca T, Craigie A, McDonald L, Edwards A, MacIsaac M, Holmes JA, Jarman M, Lee T, Huang H, Chan A, Lai M, Sundararajan V, Doyle JS, Hellard M, Stoove M, Howell J, Desmond P, Iser D, Thompson A
  PLoS One. 2020 Nov; 15(11):e0242101
• Ending malnutrition in all its forms requires scaling up proven nutrition interventions and much more: a 129-country analysis.
  Scott N, Delport D, Hainsworth S, Pearson R, Morgan C, Huang S, Akuoku JK, Piwoz E, Shekar M, Levin C, Toole M, Homer CS
  BMC Med. 2020 Nov; 18(1):356
• Impact of Victoria's Stage 3 lockdown on COVID-19 case numbers
  Saul A, Scott N, Crabb BS, Majumdar SS, Coghlan B, Hellard ME
  MJA. 2020 Nov; 213(11):494-496

October, 2020 (4)

• A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
  Ramsay J, Marsh J, Pedrana A, Andric N, Norman R, Cheng W, Webb S, Zeps N, Bellgard M, Graves T, Hellard M, Snelling T
  BMC Infect Dis. 2020 Oct; 20(1):802
• HIV infections among female sex workers in Mombasa, Kenya: current prevalence and trends over 25 years.
  Manguro GO, Gichuki C, Ampt FH, Agius PA, Lim MS, Jaoko WG, Hellard M, L'Engle K, Stoové M, Mandaliya K, Chersich MF, Temmerman M, Luchters S, Gichangi P
  Int J STD AIDS. 2020 Oct; 31(14):1389-1397
• SNP barcodes provide higher resolution than microsatellite markers to measure Plasmodium vivax population genetics.
  Fola AA, Kattenberg E, Razook Z, Lautu-Gumal D, Lee S, Mehra S, Bahlo M, Kazura J, Robinson LJ, Laman M, Mueller I, Barry AE
  Malar J. 2020 Oct; 19(1):375
• Gender inequalities in health and wellbeing across the first two decades of life: an analysis of 40 low-income and middle-income countries in the Asia-Pacific region.
  Kennedy E, Binder G, Humphries-Waa K, Tidhar T, Cini K, Comrie-Thomson L, Vaughan C, Francis K, Scott N, Wulan N, Patton G, Azzopardi P
  Lancet Glob Health. 2020 Oct; 8(12):e1473-e1488

September, 2020 (6)

• Monitoring Plasmodium falciparum and Plasmodium vivax using microsatellite markers indicates limited changes in population structure after substantial transmission decline in Papua New Guinea.
  Kattenberg JH, Razook Z, Keo R, Koepfli C, Jennison C, Lautu-Gumal D, Fola AA, Ome-Kaius M, Barnadas C, Siba P, Felger I, Kazura J, Mueller I, Robinson LJ, Barry AE
  Mol Ecol. 2020 Sep; 29(23):4525-4541
• Cost-effectiveness of uterine tamponade devices for the treatment of postpartum haemorrhage: A systematic review.
  Vogel JP, Wilson AN, Scott N, Widmer M, Althabe F, Oladapo OT
  Int J Gynaecol Obstet. 2020 Sep; 151(3):333-340
• Utility of ultra-sensitive qPCR to detect Plasmodium falciparum and Plasmodium vivax infections under different transmission intensities.
  Gruenberg M, Moniz CA, Hofmann NE, Koepfli C, Robinson LJ, Nate E, Monteiro WM, de Melo GC, Kuehn A, Siqueira AM, Nguitragool W, Bassat Q, Lacerda M, Sattabongkot J, Mueller I, Felger I
  Malar J. 2020 Sep; 19(1):319
• Authors' response to Letter to the Editor: "Colombian experience in the management of hepatitis C".
  Schroeder S, Pedrana A, Scott N, Hellard M
  Liver Int. 2020 Sep; 40(12):3142-3143
• Facilitating hepatitis B clinical management in general practice: A qualitative investigation.
  Wallace J, Richmond J, Allard N, Howell J, Adamson E, XiaoYZ, O’Reilly C, Hellard M
  Aust J Gen Pract. 2020 Sep; 49(9):599-604
• Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age.
  Howell J, Anderson D, Bloom S, Lubel J, Kemp W, Williams J, Bell S, Croagh C, Demediuk B, Desmond P, Hall S, Holmes J, Hong T, Iser D, Lim L, Papaluca T, Ryan M, Visvanathan K, Xiao Y, van Gemert C, Hellard M, Thompson A
  J Hepatol. 2020 Sep; 73(5):1282-1284

August, 2020 (10)

• Genomic Cues From Beta-Coronaviruses and Mammalian Hosts Sheds Light on Probable Origins and Infectivity of SARS-CoV-2 Causing COVID-19.
  Narh CA
  Front Genet. 2020 Aug; 11:902
• Global research priorities for social, behavioural and community engagement interventions for maternal, newborn and child health.
  Chan G, Storey JD, Das MK, Sacks E, Johri M, Kabakian-Khasholian T, Paudel D, Yoshida S, Portela A
  Health Res Policy Syst. 2020 Aug; 18(1):97
• The impact of markers of HIV infection on change in liver stiffness in people with HIV and hepatitis C virus co-infection after treatment and cure of hepatitis C.
  van Santen DK, Agius PA, Sasadeusz J, Fairley KC, Sievert W, Gane E, Iser D, O'Reilly M, Medland NA, Moore R, Hellard ME, Hoy JF, Doyle JS
  J Acquir Immune Defic Syndr. 2020 Aug; 85(5):e81-e89
• Estimates of the global reduction in liver disease-related mortality with increased coffee consumption: an analysis of the Global Burden of Disease Dataset.
  Gow P, Spelman T, Gardner S, Hellard M, Howell J
  Aliment Pharmacol Ther. 2020 Aug; 52(7):1195-1203
• A summary of the fifth annual Virology Education HIV Microbiome workshop.
  Sherrill-Mix S, Connors K, Aldrovandi GM, Brenchley J, Boucher C, Bushman F, Collman R, Dandekar S, Klatt NR, Lagenaur LA, Paredes R, Tachedjian G, Turpin JA, Landay A, Ghosh M
  AIDS Res Hum Retroviruses. 2020 Aug; 36(11):886-895
• Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
  Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, Martin-Hughes R, Teng Y, Glaubius R, Mahiane SG, Bansi-Matharu L, Taramusi I, Chagoma N, Morrison M, Doherty M, Marsh K, Bershteyn A, Hallett TB, Kelly SL; HIV Modelling Consortium
  Lancet HIV. 2020 Aug; 7(9):e929-e940
• Cost-effectiveness of strategies to improve HCV screening, linkage-to-care and treatment in remand prison settings in England.
  Mohamed Z, Scott N, Al-Kurdi D, Selvapatt N, Thursz MR, Lemoine M, Brown AS, Nayagam S.
  Liver Int. 2020 Aug; 40(12):2950-2960
• Closing the stable door after the horse has bolted - should we be treating people with immune-tolerant chronic hepatitis B to prevent hepatocellular carcinoma?
  Howell J, Chan HL, Feld JJ, Hellard ME, Thompson AJ
  Gastroenterology. 2020 Aug; 158(8):2028-2032
• Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial.
  Agius PA, Cutts JC, Oo WH, Thi A, O'Flaherty K, Aung KZ, Thu HK, Aung PP, Thein MM, Zaw NN, Htay WYM, Soe AP, Razook Z, Barry AE, Htike W, Devine A, Simpson JA, Crabb BS, Beeson JG, Pasricha N, Fowkes FJI
  PLoS Med. 2020 Aug; 17(8):e1003177
• A survey of Australian general practitioners' hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available.
  Gooey M, Wong E, Pedrana A, Allard N, Doyle J, Hellard M, Wade A
  Sex Health. 2020 Aug; 17(4):387-389

July, 2020 (9)

• A model of the economic benefits of global hepatitis C elimination: an investment case.
  Scott N, Kuschel C, Pedrana A, Schroeder S, Howell J, Thompson A, Wilson DP, Hellard M
  Lancet Gastroenterol Hepatol. 2020 Jul; 5(10):940-947
• Global hepatitis C elimination: an investment framework.
  Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus JV, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson SJ, Aufegger L, Peck R, Sohn AH, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson DP, Hellard M
  Lancet Gastroenterol Hepatol. 2020 Jul; 5(10):927-939
• Opportunities for improved HIV prevention and treatment through budget optimization in Eswatini.
  Minnery M, Mathabela N, Shubber Z, Mabuza K, Gorgens M, Cheikh N, Wilson DP, Kelly SL
  PLoS One. 2020 Jul; 15(7):e0235664
• Decreased bioefficacy of long-lasting insecticidal nets and the resurgence of malaria in Papua New Guinea.
  Vinit R, Timinao L, Bubun N, Katusele M, Robinson LJ, Kaman P, Sakur M, Makita L, Reimer L, Schofield L, Pomat W, Mueller I, Laman M, Freeman T, Karl S
  Nat Commun. 2020 Jul; 11(1):3646
• Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
  Hosseini-Hooshyar S, Martinello M, Yee J, Read P, Baker D, Post JJ, Finlayson R, Bloch M, Doyle JS, Shaw D, Hellard M, Petoumenos K, Carson J, Dore GJ, Matthews GV; CEASE study team
  AIDS. 2020 Jul; 34(9):1347-1358
• Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study.
  Draper BL, Pedrana A, Howell J, Yee WL, Htay H, Aung KS, Shilton S, Kyi KP, Naing W, Hellard M
  JMIR Res Protoc. 2020 Jul; 9(7):e16863
• The potential impact of a gel-based point-of-sex intervention in reducing gonorrhoea incidence among gay and bisexual men: a modelling study.
  Traeger MW, Tidhar T, Holt M, Williams C, Wright EJ, Stoové MA, Scott N, Hellard ME
  Sex Transm Dis. 2020 Jul; 47(10):649-657
• Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation study.
  Seaman CP, Morgan C, Howell J, Xiao Y, Spearman CW, Sonderup M, Lesi O, Andersson MI, Hellard ME, Scott N
  Lancet Glob Health. 2020 Jul; 8(7):e931-e941
• Review of Burden, Clinical Definitions, and Management of COVID-19 Cases.
  McArthur L, Sakthivel D, Ataide R, Chan F, Richards JS, Narh CA
  Am J Trop Med Hyg. 2020 Jul; 103(2):625-638

June, 2020 (8)

• The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.
  Traeger MW, Pedrana AE, van Santen DK, Doyle JS, Howell J, Thompson AJ, El-Hayek C, Asselin J, Polkinghorne V, Membrey D, Bramwell F, Carter A, Guy R, Stoové MA, Hellard ME; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood-borne Viruses and Sexually Transmitted Infections (ACCESS)
  PLoS One. 2020 Jun; 15(6):e0235445
• Privacy-Preserving Record Linkage of Deidentified Records Within a Public Health Surveillance System: Evaluation Study.
  Nguyen L, Stoové M, Boyle D, Callander D, McManus H, Asselin J, Guy R, Donovan B, Hellard M, El-Hayek C
  J Med Internet Res. 2020 Jun; 22(6):e16757
• Tracking, tracing, trust: contemplating mitigating the impact of COVID-19 through technological interventions.
  Coghlan S, Cheong M, Coghlan B
  Med J Aust. 2020 Jun; 213(2):94-94e1
• Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C.
  Deshpande P, Bundell C, McKinnon E, Hellard M, Ffrench R, Wilkinson AL, Drummer H, Gaudieri S, Lucas M
  Pathology. 2020 Jun; 52(5):576-583
• Editorial: Interplay of Infection and Microbiome.
  Huston WM, Tachedjian G
  Front Cell Infect Microbiol. 2020 Jun; 10:304
• Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019.
  Helbig KJ, Bull RA, Ambrose R, Beard MR, Blanchard H, Böcking T, Chua B, Colmant AMG, Crosse KM, Purcell DFJ, Fraser J, Hayward JA, Hamilton ST, Husain M, MacDiarmid R, Mackenzie JM, Moseley GW, Nguyen THO, Quiñones-Mateu ME, Robinson K, Rodrigo C, Rodriguez-Andres J, Rudd PA, Werno A, White P, Young P, Speck P, Hibma M, Drummer HE, Tachedjian G
  Viruses. 2020 Jun; 12(6):E621
• The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts.
  Kattenberg JH, Gumal DL, Ome-Kaius M, Kiniboro B, Philip M, Jally S, Kasian B, Sambale N, Siba PM, Karl S, Barry AE, Felger I, Kazura JW, Mueller I, Robinson LJ
  Malar J. 2020 Jun; 19(1):198
• Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study.
  Bórquez A, Rich K, Farrell M, Degenhardt L, McKetin R, Tran LT, Cepeda J, Silva-Santisteban A, Konda K, Cáceres CF, Kelly S, Altice FL, Martin NK
  J Int AIDS Soc. 2020 Jun; 23 Suppl 1:e25495

May, 2020 (6)

• A Mobile Phone-Based Sexual and Reproductive Health Intervention for Female Sex Workers in Kenya: Development and Qualitative Study.
  Ampt FH, L'Engle K, Lim MSC, Plourde KF, Mangone E, Mukanya CM, Gichangi P, Manguro G, Hellard M, Stoové M, Chersich MF, Jaoko W, Agius PA, Temmerman M, Wangari W, Luchters S
  JMIR Mhealth Uhealth. 2020 May; 8(5):e15096
• The most promising vaccines for COVID-19. (Updated 17.6.2020)
  Cunningham A, Chappell K, Copolov D, Crabb B, Cuthbertson A, Doherty P, Drummer H, Foley C, Godfrey D, Halton J, Kelleher A , Majumdar S, McDonald C, Munro T, Purcell D, Young P
  Rapid Res Infor Forum. 2020 May
• Enhancing the hepatitis B care cascade in Australia: a cost-effectiveness model.
  Xiao Y, Howell J, van Gemert C, Thompson AJ, Seaman CP, McCulloch K, Scott N, Hellard ME
  J Viral Hepat. 2020 May; 27(5):526-536
• Scaling up tuberculosis preventive therapy for contacts in high transmission settings
  Majumdar SS, Triasih R, Grham SM
  Lancet Glob Health. 2020 May; 8:e617-e618
• Shifting the paradigm: using disease outbreaks to build resilient health systems.
  Durski KN, Osterholm M, Majumdar SS, Nilles E, Bausch DG, Atun R
  BMJ Glob Health. 2020 May; 5(5):e002499
• Development and validation of serological markers for detecting recent Plasmodium vivax infection.
  Longley RJ, White MT, Takashima E, Brewster J, Morita M, Harbers M, Obadia T, Robinson LJ, Matsuura F, Liu ZSJ, Li-Wai-Suen CSN, Tham WH, Healer J, Huon C, Chitnis CE, Nguitragool W, Monteiro W, Proietti C, Doolan DL, Siqueira AM, Ding XC, Gonzalez IJ, Kazura J, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I
  Nat Med. 2020 May; 26(5):741-749

April, 2020 (5)

• A strategic framework to ease community-wide Covid-19 suppression measures.
  Coghlan B, Majumdar SS, Pedrana A, Hellard ME, Crabb BS
  MJA. 2020 Apr; Epub preprint
• Trends in human immunodeficiency virus and sexually transmitted Infection testing among gay, bisexual, and other men who have sex with men after rapid scale-up of preexposure prophylaxis in Victoria, Australiaia.
  Ryan KE, Asselin J, Fairley CK, Armishaw J, Lal L, Nguyen L, Murphy D, Traeger M, Hellard M, Hoy J, Stoové M, Wright E; PrEPX Study team
  Sex Transm Dis. 2020 Apr; 47(8):516-552
• Infectious KoRV-related retroviruses circulating in Australian bats.
  Hayward JA, Tachedjian M, Kohl C, Johnson A, Dearnley M, Jesaveluk B, Langer C, Solymosi PD, Hille G, Nitsche A, Sánchez CA, Werner A, Kontos D, Crameri G, Marsh GA, Baker ML, Poumbourios P, Drummer HE, Holmes EC, Wang LF, Smith I, Tachedjian G
  Proc Natl Acad Sci U S A. 2020 Apr; 117(7):9529–9536
• Tuberculosis contact investigation and short-course preventive therapy among young children in Africa.
  Schwoebel V, Koura KG, Adjobimey M, Gnanou S, Wandji AG, Gody JC, Delacourt C, Detjen A, Graham SM, Masserey E, Mselatti P, Roggi A, Trébucq A
  Int J Tuberc Lung Dis. 2020 Apr; 24(4):452-460
• Antimicrobial resistance in the Pacific Island countries and territories.
  Loftus M, Stewardson A, Naidu R, Coghlan B, Jenney A, Kepas J, Lavu E, Munamua A, Peel T, Sahai V, Tekoaua R, Tudravu L, Zinihite J, Cheng A, Rafai E, Peleg A
  BMJ Glob Health. 2020 Apr; 5(4):e002418

March, 2020 (7)

• Effectiveness of an Ecological Momentary Intervention for Reducing Risky Alcohol Consumption Among Young Adults: Protocol for a Three-Arm Randomized Controlled Trial.
  Wright C, Dietze PM, Kuntsche E, Livingston M, Agius PA, Room R, Raggatt M, Hellard M, Lim MSC
  JMIR Res Protoc. 2020 Mar; 9(3):e14190
• Measuring hepatitis C virus elimination as a public health threat:beyond global targets.
  van Santen DK, Sacks-Davis R, Doyle JS, Scott N, Prins M, Hellard M
  J Viral Hepat. 2020 Mar; 27(8):770-773
• Direct assessment of mental health and metabolic syndrome amongst Indonesian adolescents: a study design for a mixed-methods study sampled from school and community settings.
  Azzopardi PS, Willenberg L, Wulan N, Devaera Y, Medise B, Riyanti A, Ansariadi A, Sawyer S, Wiguna T, Kaligis F, Fisher J, Tran T, Agius PA, Borschmann R, Brown A, Cini K, Clifford S, Kennedy EC, Pedrana A, Pham MD, Wake M, Zimmet P, Durrant K, Wiweko B, Luchters S
  Glob Health Action. 2020 Mar; 13(1):1732665
• Monocytes from men living with HIV exhibit heightened atherogenic potential despite long term viral suppression with ART.
  Angelovich TA, Trevillyan JM, Hoy JF, Wong ME, Agius PA, Hearps AC, Jaworowski A
  AIDS. 2020 Mar; 34(4):513-518
• Australia needs to increase testing to achieve hepatitis C elimination.
  Scott N, Sacks-Davis R, Wade AJ, Stoové M, Pedrana A, Doyle JS, Thompson AJ, Wilson DP, Hellard ME
  Med J Aust. 2020 Mar; 212(8):365-370
• Potential health gains among key populations in West and Central Africa through savings from lower-cost HIV treatment.
  Stuart RM, Kelly SL, Martin-Hughes R, Wilson DP
  AIDS. 2020 Mar; 34(3):439-446
• The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
  Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld MJ, King CL, Weil GJ, Grobler AC, Robinson LJ, Kaldor JM, Steer AC
  PLoS Negl Trop Dis. 2020 Mar; 14(3):e0008106

February, 2020 (11)

• Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.
  Palmer A, Scott N, Dietze P, Higgs P
  Harm Reduct J. 2020 Feb; 17(1):14
• Point-of-care HIV testing can help achieve UNAIDS targets.
  Hellard M, Ryan KE, Stoové M
  Lancet HIV. 2020 Feb; 7(4):e216-e217
• A digital pornography literacy resource co-designed with vulnerable young people: Development of "The Gist"
  Davis AC, Wright CC, Murphy S, Dietze P, Temple-Smith MJ, Hellard ME, Lim MS
  J Med Internet Res. 2020 Feb; 22(6):e15964
• Tuberculosis in pregnant women and neonates: A meta-review of current evidence.
  Snow KJ, Bekker A, Huang GK, Graham SM
  Paediatr Respir Rev. 2020 Feb; 36:27-32
• A quasi-experimental text messaging trial to improve adolescent sexual and reproductive health and smoking knowledge in Indonesia.
  Pedrana AE, Pina J, Padmawati RS, Zuhrina R, Lazuardi L, Lim MSC, Hellard ME, Prabandari YS
  Sex Health. 2020 Feb; 17(2):167-177
• Blood donation amongst people who inject drugs in Australia: research supporting policy change.
  Quinn B, Pearson R, Cutts J, Seed C, Scott N, Hoad V, Dietze P, Wilson D, Maher L, Thompson A, Farrell M, Harrod M, Caris S, Pink J, Kotsiou G, Hellard M
  Vox Sang. 2020 Feb; 115(3):162-70
• Why are vaccines against many human viral diseases still unavailable; an historic perspective?
  Tannock GA, Kim H, Xue L
  J Med Virol. 2020 Feb; 92(2):129-138
• Prevalence of daily tobacco smoking participation among HIV-positive and HIV-negative Australian gay, bisexual and other men who have sex with men.
  Wilkinson A, Quinn B, Draper B, White S, Hellard M, Stoové M
  HIV Med. 2020 Feb; 21(2):e3-e4
• A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment.
  Palmer AY, Wade AJ, Draper B, Howell J, Doyle JS, Petrie D, Thompson AJ, Wilson DP, Hellard ME, Scott N
  Int J Drug Policy. 2020 Feb; 76:102633
• HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
  Bowring AL, Ampt FH, Schwartz S, Stoové MA, Luchters S, Baral S, Hellard M
  J Int AIDS Soc. 2020 Feb; 23(2):e25442
• Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational study.
  Marukutira T, Gunaratnam P, Douglass C, Jamil MS, McGregor S, Guy R, Gray RT, Spelman T, Horyniak D, Higgins N, Giele C, Crowe SM, Stoové M, Hellard M
  Medicine. 2020 Feb; 99(8):e19289

January, 2020 (13)

• Cost-effectiveness of transplanting lungs and kidneys from donors with potential hepatitis C exposure or infection.
  Scott N, Snell G, Westall G, Pilcher D, Raggatt M, Walker RG, Hellard M, Peleg AY, Doyle J
  Sci Rep. 2020 Jan; 10(1):1459
• Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review.
  Cutts JC, Agius PA, Zaw Lin, Powell R, Moore K, Draper B, Simpson JA, Fowkes FJI
  BMC Med. 2020 Jan; 18(1):14
• Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
  Delgado-Diaz DJ, Tyssen D, Hayward JA, Gugasyan R, Hearps AC, Tachedjian G
  Front Cell Infect Microbiol. 2020 Jan; 9:446
• Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.
  Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; InC3 Collaborative.
  Clin Infect Dis. 2020 Jan; 70(1):123-131
• Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs.
  Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, Hellard ME
  Clin Infect Dis. 2020 Jan; 70(9):1900-1906
• Moving towards hepatitis C micro-elimination among people living with HIV in Australia: the CEASE study.
  Martinello M, Yee J, Bartlett SR, Read P, Baker D, Post JJ, 7, 8, Finlayson R, Bloch M, Doyle J, Shaw D, Hellard M, Petoumenos K, Lin L, Marks P, Applegate T, Dore GJ, Matthews GV; CEASE study team
  Clin Infect Dis. 2020 Jan; 71(6):1502-1510
• Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.
  Cunningham EB, Hajarizadeh B, Amin J, Litwin AH, Gane E, Cooper C, Lacombe K, Hellard M, Read P, Powis J, Dalgard O, Bruneau J, Matthews GV, Feld JJ, Dillon JF, Shaw D, Bruggmann P, Conway B, Fraser C, Marks P, Dore GJ, Grebely J
  Clin Infect Dis. 2020 Jan; 71(7):E115-E124
• The Elimination of Hepatitis C as a Public Health Threat.
  Hellard M, Schroeder SE, Pedrana A, Doyle J, Aitken C
  Cold Spring Harb Perspect Med. 2020 Jan; 10(4):a036939
• Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure.
  Stoové M, Wallace J, Higgs P, Pedrana A, Goutzamanis S, Latham N, Scott N, Treloar C, Crawford S, Doyle J, Hellard M
  Int J Drug Policy. 2020 Jan; 75:102596
• Adolescent tuberculosis.
  Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, Dood PJ, Houben RM, Denholm JT, Sawyer SM, Kranzer K
  Lancet Child Adolesc Health. 2020 Jan; 4(1):68-79
• A descriptive analysis of young women's pornography use: a tale of exploration and harm
  Davis AC, Temple-Smith MJ, Carrotte E, Hellard ME, Lim MSC
  Sex Health. 2020 Jan; 17:69-76
• Standardised shorter regimens versus individualised longer regimens for multidrug-resistant TB.
  Abidi S, Achar J, Neino MMA, Bang D, Benedetti A, Brode S, Campbell JR, Casas E, Conradie F, Dravniece G, du Cros P, Falzon D, Jaramillo E, Kuaban C, Lan Z, Lange C, Li PZ, Makhmudova M, Maug AKJ, Menzies D, Migliori GB, Miller A, Myrzaliev B, Ndjeka N, Noeske J, Parpieva N, Piubello A, Schwoebel V, Sikhondze W, Singla R, Souleymane MB, Trébucq A, Van Deun A, Viney K, Weyer K, Zhang BJ, Khan FA
  Eur Respir J. 2020 Jan; 55(3):1901467
• 'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package.
  Xiao Y, van Gemert C, Howell J, Adamson E, Towell V, Cowie BC, Thompson AJ, Hellard M
  Aust J Gen Pract. 2020 Jan; 49(1-2):66-69